LIGAND PHARMACEUTICALS
LGNDNASDAQ🏆 #1101 by market capEarnings Oct 29 · PreUS Equity
$318.78▲ $7.05 (+2.26%)
Market closed · at closeTrack LGND
Get earnings, price moves & breaking news on Telegram
24h▲ 2.3%
7d▲ 3.6%
14d▲ 6.7%
30d▲ 2.8%
ytd▲ 68.6%
1y▲ 72.2%
🏦Market Cap
$6.36B
Small Cap
📈Revenue Growth (YoY)
54.9%
High Growth
📊Gross Margin
95.4%
High
💵FCF Margin
46.2%
Strong
⚖️P/S Ratio
21.3x
Expensive
Otter Score
68
Fair
LIGAND PHARMACEUTICALS
LGNDAnalyst Ratings
Price
$318.78
Total
18
Raised
0
Lowered
3
Avg PT
$339.43
H / L
$358 / $326
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-24 | — | — |
Citigroup | Reiterated | Buy | 2026-09-23 | — | — |
RBC Capital | Reiterated | Outperform | 2026-08-07 | $340.00 | +6.70% |
Oppenheimer | Reiterated | Outperform | 2026-08-03 | $326.00 | +2.30% |
B of A Securities | Reiterated | Buy | 2026-07-09 | — | — |
Stifel | Reiterated | Buy | 2026-07-08 | — | — |
Benchmark | Reiterated | Buy | 2025-11-07 | — | — |
Barclays | Reiterated | Overweight | 2024-12-16 | $345.00 | +8.20% |
Craig-Hallum | Reiterated | Buy | 2024-07-09 | $345.00 | +8.20% |
Roth Capital | Reiterated | Buy | 2022-12-23 | $90.00 | −71.80% |
Stephens & Co. | Reiterated | Overweight | 2022-05-16 | — | — |
Argus Research | Downgraded | Buy → Hold | 2020-03-24 | — | — |
H.C. Wainwright | Reiterated | Buy | 2018-09-19 | $358.00 | +12.30% |
Deutsche Bank | Downgraded | Hold → Sell | 2017-11-20 | — | — |
CJS Securities | Reiterated | Market Perform | 2015-06-22 | — | — |
Cantor Fitzgerald | Reiterated | Hold | 2015-06-19 | — | — |
McNicoll Lewis Vlak | Reiterated | Buy | 2014-02-13 | — | — |
Brean Capital | Downgraded | Buy → Hold | 2013-10-31 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-24
—
—
Citigroup
Reiterated · Buy · 2026-09-23
—
—
RBC Capital
Reiterated · Outperform · 2026-08-07
$340.00
+6.70%
Oppenheimer
Reiterated · Outperform · 2026-08-03
$326.00
+2.30%
B of A Securities
Reiterated · Buy · 2026-07-09
—
—
Stifel
Reiterated · Buy · 2026-07-08
—
—
Benchmark
Reiterated · Buy · 2025-11-07
—
—
Barclays
Reiterated · Overweight · 2024-12-16
$345.00
+8.20%
Craig-Hallum
Reiterated · Buy · 2024-07-09
$345.00
+8.20%
Roth Capital
Reiterated · Buy · 2022-12-23
$90.00
−71.80%
Stephens & Co.
Reiterated · Overweight · 2022-05-16
—
—
Argus Research
Downgraded · Buy → Hold · 2020-03-24
—
—
H.C. Wainwright
Reiterated · Buy · 2018-09-19
$358.00
+12.30%
Deutsche Bank
Downgraded · Hold → Sell · 2017-11-20
—
—
CJS Securities
Reiterated · Market Perform · 2015-06-22
—
—
Cantor Fitzgerald
Reiterated · Hold · 2015-06-19
—
—
McNicoll Lewis Vlak
Reiterated · Buy · 2014-02-13
—
—
Brean Capital
Downgraded · Buy → Hold · 2013-10-31
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space